Remove Hospital Remove Safety Remove Treatments
article thumbnail

Arch Amenities’ Catherine Warren on technology & creating memorable experiences.

Spa Executive

We asked her about what she does, technology’s role in the hospitality and wellness space, and creating memorable experiences. Travel itself is inherently taxing on the mind and body, making it essential for hospitality providers to address these aspects to ensure a truly restorative experience.

article thumbnail

Increasing Rate of Medical Mistakes and Misdiagnosis

Aesthetics Advisor

1 Among hospitalized adults who died or were transferred to the intensive care unit (ICU), diagnostic errors are also disturbingly common. 3 US Facing a Medical Emergency of Misdiagnoses When you visit a doctor, whether you’re at a doctor’s office or hospital, you depend on getting expert care, including a correct diagnosis.

Medical 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meet the First-ever Recipients of The Lupus Research Alliance’s Translational Bridge Award

The Dermatology Digest

This award was established this year to accelerate the translation of research into potential treatments and diagnostics for lupus. He will test ONT01, which has shown promising results in mouse models, in a phase 1b trial to assess its safety in people with lupus.

article thumbnail

Upadacitinib Now Available for Pediatric Patients with PsA, pJIA

The Dermatology Digest

as a tablet or an oral solution for the treatment of pediatric patients aged 2 and older with active psoriatic arthritis (PsA) as well as polyarticular juvenile idiopathic arthritis (pJIA), provided patients have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers, AbbVie reports.

article thumbnail

FLCCC I-CARE Early Treatment Protocol Review (2023)

Aesthetics Advisor

Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the I-MASK+ protocol for prophylaxis and at home treatment of early stage COVID-19 and has now divided the I-MASK protocol into I-CARE and I-PREVENT protocols. Treatment is therefore highly stage-specific. Treatment of BA.4/BA.5/BQ.1.1

article thumbnail

And the Winners Are…PeDRA Announces 2023 Grant Recipients

The Dermatology Digest

The 2023 PeDRA Research Grant recipients are: Joyce Teng, MD, PhD of Stanford University, will conduct a project titled “ A Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of a Hypertonic Gel in the Treatment of Pediatric Cutaneous Pyogenic Granuloma.

article thumbnail

Sanofi’s OX40-ligand Blocker Produces High Durable Response Rates in AD With Quarterly Dosing

The Dermatology Digest

Sanofi’s investigational OX40-ligand blocker amlitelimab produces sustained improvement in the signs and symptoms of atopic dermatitis (AD) in adults who previously responded and continued treatment and sustained off-drug improvements in those who stopped treatment. of patients withdrawn from treatment, the study showed.